Medtronic Amount that if recognized, would affect the effective tax rate or regulatory liability remained flat by 0.0% to $2.70B in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.70B to $2.70B. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate greater potential volatility in future earnings due to tax audit outcomes.
The portion of unrecognized tax benefits that, if recognized, would directly impact the company's effective tax rate. Th...
Commonly reported by large-cap firms; peers with stable tax profiles generally maintain lower ratios of this metric relative to total tax expense.
other_unrecognized_tax_benefits_that_would_impact_effect_ff36cb| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.60B | $1.60B | $1.60B | $1.60B | $2.40B | $2.40B | $2.60B | $2.60B | $2.60B | $2.70B | $2.70B | $2.70B | $2.70B | $2.70B | $2.70B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +50.0% | +0.0% | +8.3% | +0.0% | +0.0% | +3.8% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +0.0% | +50.0% | +50.0% | +62.5% | +8.3% | +8.3% | +3.8% | +3.8% | +3.8% | +0.0% | +0.0% | +0.0% |